Haleon, the consumer healthcare company behind brands including Sensodyne, Panadol and Tums, has appointed a new chair.

With Kimberly-Clark shelling out nearly $49 billion to buy Kenvue, which was originally J&J’s over-the-counter medicine ...

The outgoing pharma chief exec (pictured) said it was 'absolutely critical' that the government 'incentivise' investment in the sector.

GSK has successfully appealed a ruling by the U.K. marketing watchdog that determined a trio of its COVID-19 vaccine press releases had brought discredit on the pharma industry. The case is the latest ...

GSK plc announces its CEO transition, with CCO Luke Miels to succeed Emma Walmsley, as shares rise 3% and the company maintains a 4% dividend yield. GSK's strengths include its HIV, vaccines, and ...

Shares of GSK rallied on Monday after the U.K. pharmaceutical giant turned to an insider to become its next CEO. Luke Miels, chief commercial officer, will take the reigns on Jan. 1 from Emma Walmsley ...

A little less than a year after targeting Moderna in an mRNA vaccine patent lawsuit, GSK is widening the scope of its litigation by throwing its rival’s next-generation COVID-19 shot into the fold. In ...

GSK agreed to buy an experimental medicine from a Cambridge biotech for as much as $2 billion to shore up its drug pipeline and muscle into the promising field of liver therapies. The treatment, made ...